Wednesday, July 8, 2026

pharma · Hyperphagia · Bariatric Surgery · AARD

Ark Therapeutics

Ark Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Boulder, USA HQ
2025 Founded
4 Employees
Public company Type
AARD · NYSE Ticker
Company details
Status
Public
HQ
Boulder, USA
Founded
2025
Employees
4
Programs
6
Drugs
5
Patents
7
Intelligence · Clinical Trials

Ark Therapeutics clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Ark Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Ark Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Ark Therapeutics.

  1. Low Dose ARD-501 — Phase 2

    Clinical update
  2. Placebo — Phase 3

    Clinical update
  3. ARD-101 — Phase 3

    Clinical update
  4. ARD-101 — Phase 2

    Clinical update
  5. ARD-101 — Phase 2

    Clinical update
  6. ARD-101 — Phase 2

    Clinical update

Trial registry

6 studies